1. Bailong tablet and chemotherapy in the treatment of moderate and advanced cancersand chemotherapy in the treatment of moderate and advanced cancers
- Author
-
Liu Xinduo, Wang Daishu, Liang Yunyan, Zhang Xinqi, and Liu Shu-jun
- Subjects
Treated group ,medicine.medical_specialty ,Chemotherapy ,Karnofsky Performance Status ,business.industry ,medicine.medical_treatment ,Therapeutic effect ,General Medicine ,Gastroenterology ,Complementary and alternative medicine ,Internal medicine ,Medicine public health ,Medicine ,Pharmacology (medical) ,business ,After treatment - Abstract
Objective: To determine the effectiveness of Bailong Tablet Open image in new window and chemotherapy on treatment of moderate and advanced cancers.Methods: The patients were divided randomly into two groups. The treated group (n= 41) was treated with chemotherapy plus Bailong Tablet; and the control group (n= 22) treated with chemotherapy alone. Treatment effectiveness was measured with Karnofsky scores.Results: Karnofsky performance status in the treated group before and after treatment was 66.0 ± 8.7 and 68.0 ± 5.9 respectively, that in the control group was 67. 0 ± 6.8 and 53. 0 ± 7.3 respectively. The completion rate of chemotherapy in the treated group (92.6%, 38/41) was higher than that in control (77.2%, 17/22,P < 0.05). The side-effects caused by chemotherapy in the treated group were lower than that in the control group (P < 0.05). CD3+, CD4+ and CD4+ /CD8+ ratio were higher in the treated group.Conclusion: Bailong Tablet can enhance the therapeutic effect and reduce the side-effects of chemotherapy. One possible mechanism is the modulation of cellular immune function.
- Published
- 1998
- Full Text
- View/download PDF